Senior Director, Product Development,
Dagmar Beyerlein has 17-years of product development and leadership experience at Guidant Corporation, Abbott Vascular, Stryker Neurovascular and Drawbridge Health. Dagmar has led cross-functional teams responsible for all aspects of the research and product development life cycle: early product definition and concept development; design verification, validation, and clinical trials; global regulatory submissions and market launch. Dagmar’s teams developed and brought 14 products to market, including several within the blockbuster, market-leading Xience family of drug-eluting stents. Her teams’ development portfolio resulted in over $2 billion in annual revenues. She holds 13 patents in semiconductor and medical device technologies.